Over the last 5 years the Duke Comprehensive Cancer Center has undergone substantial growth and renewal. A new Director and Deputy Director have been appointed. The Cancer Center membership has been mobilized. A strategic plan is being developed to facilitate communication, collaboration and interaction among Cancer Center members and to enhance educational, community and patient care activities. Some 201 members from 12 Departments participate in 11 Programs and utilize 16 Shared Resources. The Molecular Biology Shared Resource has been significantly strengthened, computer facilities have been updated, the Isolation Facility has been doubled in size and new resources have been created for biofermentation, irradiation, production of transgenic mice, conjugation of radionuclides, NMR spectroscopy, generation of LAK cells, measurement of hematopoietic colonies and autologous bone marrow transplantation. Organizationally, a matrix design has been converted into a matrix-plus. A Section of Cell Growth Regulation has been created, permitting the primary recruitment of 14-16 new investigators whose work is directly relevant to tumor biology. The Medical Center has committed a quasi-endowment and 34,500 new sf of research space to back this recruitment. During the. current grant period clinical programs in surgical and pediatric oncology have continued to mature and new leaders have been recruited in medical oncology, radiation oncology, gynecologic oncology and biostatistics. Support is requested for Staff, Programs, Shared Resources and Development to implement fully the strategic plan for the Duke Comprehensive Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-18
Application #
3101403
Study Section
Special Emphasis Panel (SRC (A2))
Project Start
1976-09-01
Project End
1993-12-31
Budget Start
1991-01-01
Budget End
1991-12-31
Support Year
18
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Lu, Min; Sanderson, Sydney M; Zessin, Amelia et al. (2018) Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer. Cancer Metab 6:14
Qian, Danwen; Liu, Hongliang; Wang, Xiaomeng et al. (2018) Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival. Int J Cancer :
Ashcraft, Kathleen A; Choudhury, Kingshuk Roy; Birer, Sam R et al. (2018) Application of a Novel Murine Ear Vein Model to Evaluate the Effects of a Vascular Radioprotectant on Radiation-Induced Vascular Permeability and Leukocyte Adhesion. Radiat Res 190:12-21
Ong, Cecilia T; Campbell, Brittany M; Thomas, Samantha M et al. (2018) Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database. Ann Surg Oncol 25:2249-2260
Duan, Bensong; Hu, Jiangfeng; Liu, Hongliang et al. (2018) Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Int J Cancer 142:1322-1331
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031

Showing the most recent 10 out of 513 publications